GL1X · GenesisL1 explorer

MolNFT v1 · #141255 · protein

MAP2K7 C218S mutant-inhibitor

5Z1E · Dual specificity mitogen-activated protein kinase kinase 7: “MAP2K7 C218S mutant-inhibitor”. X-ray diffraction, 1 ligand (95U), 3 pockets (best druggability 0.57). MolNFT v1 #141255 on GenesisL1: 3D structure, binding sites and…

PDB
5Z1E
Type
protein
Length
296 residues
Chains
1
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Dual specificity mitogen-activated protein kinase kinase 7
EC
2.7.12.2
UniProt
O14733
Ligands
95U
Pockets
3 · best druggability 0.57

Structure

x-ray diffraction · 1 distinct chain · 39% helix, 17% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
ADual specificity mitogen-activated protein kinase kinase 7 (EC 2.7.12.2)protein29639% helix, 17% strandO14733

Ligands and binding sites

  • 95U · N-[3-(6-methyl-1H-indazol-3-yl)phenyl]prop-2-enamide · ligand · chains A

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

3 pockets found on a 1 Å grid, 1 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
12610.570.783195U
2740.310.7417empty
3510.250.7313empty

Compared structures

  • 5Z1E · MAP2K7 C218S mutant-inhibitor · the same entry in another collection · chain A against A, TM-score 1.00
  • O14733 · AlphaFold monomer V2.0 prediction for dual specificity mitogen- activated protein kinase… · a predicted model of the same protein · chain A against A, TM-score 0.90

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.